13 days ago
40
0
Posted On: October 7th 2026, 08:00 pm
An injectable treatment for frown lines between the brows,¹ with results that may last up to 5 months.²⁻⁴*
That’s Dysport®.
Ask your specialist if Dysport® is right for you.
Join ASPIRE for $50 toward your first Dysport® treatment: aspirerewards.com. Terms and conditions apply.
*GL-1 and GL-3 evaluated subjects for at least 150 days following treatment. Based on a ≥1-Grade GLSS improvement from baseline utilizing data from two double-blinded, randomized, placebo-controlled pivotal studies (GL-1, GL-3) in a post-hoc analysis.
1. Dysport Prescribing Information. Galderma Laboratories, L.P. 2023.
2. Monheit GD, et al. Dermatol Surg. 2020;46(1):61-69.
3. Brandt F, et al. Dermatol Surg. 2009;35(12):1893-1901.
4. Data on file. MA-35497. Post Hoc Analysis. Fort Worth, TX: Galderma Laboratories, L.P., 2017.
Swipe left for full Important Safety Information, including Distant Spread of Toxin Effect Boxed Warning. For full Product Information, including Boxed Warning and Medication Guide, see @dysportusa.
Dysport® (abobotulinumtoxinA) is a prescription injection for temporary improvement in the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults less than 65 years of age. The most common side effects include nose and throat irritation, headache, injection site pain, injection site skin reaction, upper respiratory tract infection, eyelid swelling, eyelid drooping, sinus inflammation, and nausea.
That’s Dysport®.
Ask your specialist if Dysport® is right for you.
Join ASPIRE for $50 toward your first Dysport® treatment: aspirerewards.com. Terms and conditions apply.
*GL-1 and GL-3 evaluated subjects for at least 150 days following treatment. Based on a ≥1-Grade GLSS improvement from baseline utilizing data from two double-blinded, randomized, placebo-controlled pivotal studies (GL-1, GL-3) in a post-hoc analysis.
1. Dysport Prescribing Information. Galderma Laboratories, L.P. 2023.
2. Monheit GD, et al. Dermatol Surg. 2020;46(1):61-69.
3. Brandt F, et al. Dermatol Surg. 2009;35(12):1893-1901.
4. Data on file. MA-35497. Post Hoc Analysis. Fort Worth, TX: Galderma Laboratories, L.P., 2017.
Swipe left for full Important Safety Information, including Distant Spread of Toxin Effect Boxed Warning. For full Product Information, including Boxed Warning and Medication Guide, see @dysportusa.
Dysport® (abobotulinumtoxinA) is a prescription injection for temporary improvement in the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults less than 65 years of age. The most common side effects include nose and throat irritation, headache, injection site pain, injection site skin reaction, upper respiratory tract infection, eyelid swelling, eyelid drooping, sinus inflammation, and nausea.
More posts
